BOSTON — Patients with non-BRCA gene mutations undergoing risk-reduction surgery to prevent tubo-ovarian cancers showed no signs of tubo-ovarian high-grade serous carcinoma or serous tubal intraepithelial carcinoma compared with about 3% incidence of these carcinomas in patients with BRCA mutations in a multi-center study. “We need to define the role of risk-reduction surgery in reducing […]
The post Risk-Reduction Surgery Benefit in Non-BRCA Ovarian Cancer? first appeared on News Health.
Author : News Health
Publish date : 2025-03-26 08:14:00
Copyright for syndicated content belongs to the linked Source.